Evidence map›Paper›PMID 42889921›Full record

ArticleACS omega2026

4‑

Gabriel Candido Moura, Stephanie Ortega Alves, Ingrid de Oliveira Dias, João Paulo Dos Santos Fernandes, Daniela da Costa Tristão, João Henrique Ghilardi Lago, Juliana Quero Reimão

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriel Candido MouraLaboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Faculdade de Medicina de Jundiaí, Jundiaí, São Paulo 13202-550, Brazil.ORCID https://orcid.org/0000-0002-1256-057X
Stephanie Ortega AlvesLaboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Faculdade de Medicina de Jundiaí, Jundiaí, São Paulo 13202-550, Brazil.
Ingrid de Oliveira DiasLaboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Faculdade de Medicina de Jundiaí, Jundiaí, São Paulo 13202-550, Brazil.
João Paulo Dos Santos FernandesInstitute of Environmental, Chemical and Pharmaceutical Sciences, Universidade Federal de São Paulo, 09972-270 Diadema, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-9089-273X
Daniela da Costa TristãoCenter of Natural and Human Sciences, Federal University of the ABC, 09210-580 Santo Andre, São Paulo, Brazil.
João Henrique Ghilardi LagoCenter of Natural and Human Sciences, Federal University of the ABC, 09210-580 Santo Andre, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-1193-8374
Juliana Quero ReimãoLaboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Faculdade de Medicina de Jundiaí, Jundiaí, São Paulo 13202-550, Brazil.ORCID https://orcid.org/0000-0002-4418-0838

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42889921
PMCPMC13670340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.